PillRx only · Capsule, Extended Release · Oral
Phentermine And Topiramate
Brands: Qsymia · Phentermine Hydrochloride + Topiramate
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$3.269
Latest avg · Jul 22, 2026
-13%
Since Dec 17, 2025
3
Active US suppliers
69%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
1.6K
Rx · 2026 Q1
43K
Units dispensed
4
Quarters · since 2025 Q2
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| VIVUS LLC | unknown | 5 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 4 | SUPPLYING |
| Prasco Laboratories | unknown | 4 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.